SCHEMBL3177178

SCHEMBL3177178

CC(=O)NCCNc1nc(-c2ccccc2)nc(NCCNC(=O)c2cccc(Br)c2)c1C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.56
ADORA1 P30542 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.51
CYP1A2 P05177 7/20 0.50
CYP3A4 P08684 7/20 0.50
CYP2D6 P10635 6/20 0.50
CLK4 Q9HAZ1 6/20 0.50
TSHR P16473 3/20 0.50
CYP2C19 P33261 3/20 0.50
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
ALDH1A1 P00352 7/20 0.49
USP2 O75604 2/20 0.49
MAPT P10636 4/20 0.48
LMNA P02545 3/20 0.48
KDM4E B2RXH2 2/20 0.48
HSD17B10 Q99714 2/20 0.48
TP53 P04637 2/20 0.48
ALOX15 P16050 1/20 0.48
RECQL P46063 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3170464 0.91 L3MBTL1 (0.48) ADORA2AADORA1L3MBTL1CYP1A2CYP3A4
SCHEMBL3175889 0.89 ADORA2A (0.58) ADORA2AADORA1CYP1A2CYP3A4CYP2D6
SCHEMBL3165096 0.89 ADORA2A (0.65) ADORA2AADORA1CYP1A2CYP3A4CYP2D6
SCHEMBL3161464 0.87 L3MBTL1 (0.53) ADORA2AADORA1L3MBTL1CYP1A2CYP3A4
SCHEMBL3262017 0.87 ADORA2A (0.55) ADORA2AADORA1CYP1A2CYP3A4CYP2D6
SCHEMBL3162050 0.85 ADORA2A (0.72) ADORA2AADORA1CYP1A2CYP3A4CYP2D6
SCHEMBL3256770 0.85 CYP1A2 (0.67) ADORA2AADORA1CYP1A2CYP3A4CYP2D6
SCHEMBL3172317 0.85 ADORA2A (0.53) ADORA2AADORA1CYP1A2CYP3A4CYP2D6
SCHEMBL3171963 0.85 ADORA2A (0.60) ADORA2AADORA1CYP1A2CYP3A4CYP2D6
SCHEMBL3172990 0.84 ADORA2A (0.61) ADORA2AADORA1CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed